Gonococcal Arthritis Workup
- Author: Michael P Keith, MD, FACP, FACR; Chief Editor: Herbert S Diamond, MD more...
Laboratory Studies
Cultures of likely sites of gonococcal infection are the most important tests to perform for the diagnosis of disseminated gonococcal infection (DGI). Synovial fluid cultures are positive for N gonorrhoeae in no more than 50% of cases[1] and alone are insufficient to make a diagnosis of DGI. In addition to synovial fluid culture, cultures of blood, cervix, rectum, urethra, and pharynx should be taken.[7] Positive culture results help confirm the diagnosis of DGI and provide antibiotic sensitivities for the particular infecting strain of the organism.
Other laboratory tests that are useful in DGI or gonococcal arthritis include the following:
- Complete blood cell count: Most cases involve mild leukocytosis.
- Erythrocyte sedimentation rate (ESR): This is elevated in most cases.
- Synovial fluid analysis
- Cell count: The cell count is usually greater than 50,000 WBC/µL (typically >90% polymorphonuclear cells). Synovial fluid with this much inflammation may appear purulent.
- Analysis for crystals
- Gram stain: Gram-negative intracellular organisms may be demonstrated, although in less than 25% of synovial fluid aspirates.
- Culture: Note that synovial fluid should be cultured on prewarmed chocolate agar for highest yield (positive findings in only 50% of patients with gonococcal arthritis and 25%-30% of patients with DGI).
- Culture of mucosal surfaces: Yield is highest if the culture is obtained from the primary infection site. Findings are positive in more than 80% of cases. When obtained from the primary site of infection, 90% of results are positive in cervical samples, 50%-75% in male urethral samples, 20% in pharyngeal samples, and 15% in rectal samples.[1] The pharynx is an important site of infection in pregnant women and in men who have sex with men (MSM). Mucosal surface cultures should be placed on prewarmed selective plates (ie, Thayer-Martin, modified New York media) and blood agar for identification of other possible organisms.
- Urine culture: Culture is noted to produce a higher yield if the sample is the first-void urine (FVU) from the first 20 mL of the void.
- Rectal culture: The swab is inserted approximately 2.5 cm into the canal (ie, to crypts of Morgagni, which is a frequent focus of infection).
- Blood cultures: Bottled blood culture media containing sodium polyethylene sulfate (SPS) inhibits growth.
Imaging Studies
- Plain radiography findings of the affected joint are usually normal. However, they may be indicated to exclude articular damage and to rule out other processes, such as fracture.
Other Tests
- Nucleic acid amplification tests (NAATs): NAATs may be used as an adjunct to culture and can be performed on samples from the cervix, urethra, rectum, urine, pharynx, synovial fluid,[8] and skin[9] . These tests can help to confirm a diagnosis of DGI when cultures are negative.[8, 9, 10] However, an important limitation of polymerase chain reaction (PCR) or other NAATs is they do not provide antibiotic sensitivities to guide choice of antibiotic for treatment.
Procedures
- Arthrocentesis is mandatory in cases of suspected septic arthritis.
- Laboratory tests typically performed on synovial fluid include cell count, crystal analysis, Gram stain, and culture (see Lab Studies).
- Repeat arthrocentesis should be performed when inflammatory synovial effusions recur in order to remove inflammatory mediators, debris, and purulence.
- Surgical drainage may be needed in joints refractory to drainage via arthrocentesis; however, this is rarely necessary in gonococcal arthritis.
Histologic Findings
Biopsy of skin lesions shows dermal vasculitis with perivascular neutrophils. Neutrophilic infiltration of the epidermis may also be seen in pustular lesions.
Dalla Vestra M, Rettore C, Sartore P, Velo E, Sasset L, Chiesa G, et al. Acute septic arthritis: remember gonorrhea. Rheumatol Int. Nov 2008;29(1):81-5. [Medline].
Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol. Apr 2003;17(2):201-8. [Medline].
Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am. Dec 2005;19(4):853-61. [Medline].
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2005 supplement, gonococcal isolate surveillance project (GISP) Annual Report 2005. Atlanta, GA. US Department of Health and Human Services, Centers for Disease Control and Prevention, January 2007. Available at http://www.cdc.gov.std.gisp2005/. Accessed May 12, 2009.
World Health Organization Fact Sheet Number 110. Available at http://www.who.int/mediacentre/factsheets/fs110/en/index.html. Accessed May 12, 2009.
Marker-Hermann E. Septic arthritis, osteomyelitis, gonococcal and syphilitic arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 4th ed. Philadelphia, PA: Mosby Elsevier; 2008:1013-28.
Davis BT, Pasternack MS. Case records of the Massachusetts General Hospital. Case 19-2007 - a 19-year-old college student with fever and joint pain. N Engl J Med. Jun 21 2007;356(25):2631-7. [Medline].
Liebling MR, Arkfeld DG, Michelini GA, Nishio MJ, Eng BJ, Jin T, et al. Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum. May 1994;37(5):702-9. [Medline].
Read P, Abbott R, Pantelidis P, Peters BS, White JA. Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swab. Sex Transm Infect. Oct 2008;84(5):348-9. [Medline].
Kimmitt PT, Kirby A, Perera N, Nicholson KG, Schober PC, Rajakumar K, et al. Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCR. J Travel Med. Sep-Oct 2008;15(5):369-71. [Medline].
Update to CDC's Sexually Transmitted Diseases Treatment Guidelines 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm. Accessed May 1, 2009.
[Guideline] Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR. 2006;55(No. RR-11):42-49.
[Guideline] Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR. RR-12;59:49-55. [Medline].
MMWR. Availability of Cefixime 400 mg tablets---United States, April 2008. Available at http://www.cdc.gov.mmwr/preview/mmwrhtml/mm5716a5.htm. Accessed May 1, 2009.
Centers for Disease Control and Prevention. Notice to readers: discontinuation of spectinomycin. MMWR. 2006;55:370.

